KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organon (OGN) Other Non Operating Income (2020 - 2025)

Historic Other Non Operating Income for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $30.0 million.

  • Organon's Other Non Operating Income rose 60000.0% to $30.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.0 million, marking a year-over-year increase of 20857.14%. This contributed to the annual value of -$26.0 million for FY2024, which is 3809.52% up from last year.
  • According to the latest figures from Q3 2025, Organon's Other Non Operating Income is $30.0 million, which was up 60000.0% from $35.0 million recorded in Q2 2025.
  • Organon's Other Non Operating Income's 5-year high stood at $35.0 million during Q2 2025, with a 5-year trough of -$36.0 million in Q4 2022.
  • Moreover, its 5-year median value for Other Non Operating Income was -$6.0 million (2024), whereas its average is -$3.5 million.
  • Per our database at Business Quant, Organon's Other Non Operating Income plummeted by 350000.0% in 2022 and then surged by 68333.33% in 2025.
  • Organon's Other Non Operating Income (Quarter) stood at -$1.0 million in 2021, then crashed by 3500.0% to -$36.0 million in 2022, then soared by 52.78% to -$17.0 million in 2023, then rose by 11.76% to -$15.0 million in 2024, then surged by 300.0% to $30.0 million in 2025.
  • Its Other Non Operating Income stands at $30.0 million for Q3 2025, versus $35.0 million for Q2 2025 and -$12.0 million for Q1 2025.